このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Comparison of the Effect of Lung-protective Ventilation on Optic Nerve Sheath Diameter in Obese and Non-obese Patients

2026年11月9日 更新者:Gulay ERDOGAN KAYHAN、Eskisehir Osmangazi University

Comparison of the Effect of Recruitment Maneuver and Individualized Positive End-expiratory Pressure on Optic Nerve Sheath Diameter in Obese and Non-obese Patients Undergoing Laparoscopic Surgery

The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers-employed as part of an intraoperative lung-protective ventilation strategy-and individualized positive end-expiratory pressure (PEEP) on intracranial pressure, as assessed by measuring the optic nerve sheath diameter, in both obese and non-obese patients undergoing laparoscopic surgery.

調査の概要

状態

まだ募集していません

条件

介入・治療

詳細な説明

Laparoscopy is widely used due to its advantages, such as less blood loss, reduced postoperative pain, and faster recovery. However, pneumoperitoneum increases thoracoabdominal pressure, which decreases venous drainage from the brain and increases cerebral blood flow and intracranial pressure (ICP). The optic nerve sheath diameter (ONSD) measurement via ultrasound is a non-invasive and reliable method for assessing ICP.

The prevalence of obesity has increased substantially over recent decades, accompanied by a growing number of obese patients undergoing laparoscopic surgery. Obesity is associated with increased intra-abdominal pressure, which may contribute to an increase in ONSD. Furthermore, the additional rise in intra-abdominal pressure induced by pneumoperitoneum may exacerbate these effects, potentially placing obese patients at greater risk of alterations in cerebral haemodynamics during laparoscopic procedures.

Atelectasis occurs in roughly 90% of all patients undergoing general anaesthesia and can persist for weeks after operation. Intraoperative lung-protective ventilation has been recommended to reduce postoperative pulmonary complications after abdominal and/or laparoscopic surgery and also in obese patients. Decreasing compliance caused by surgical/ anaesthesia factors (i.e. pneumoperitoneum, positioning, and circuit disconnect) should be treated by appropriate interventions. Individualised PEEP and alveolar recruitment manoeuvres can prevent and reverse alveolar collapse, respectively.

However, the effects of these interventions on cerebral haemodynamics, particularly ICP as assessed indirectly by ONSD measurement, remain insufficiently understood in obese and non-obese patients undergoing laparoscopic surgery.

The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers and individualized PEEP- as part of intraoperative lung-protective ventilation strategy- on intracranial pressure, as assessed by measuring the optic nerve sheath diameter (ONSD), in both obese and non-obese patients undergoing laparoscopic surgery.

研究の種類

介入

入学 (推定)

70

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Gulay Erdogan Kayhan, Prof. Dr.
  • 電話番号:905332560011
  • メール:drgulayer@yahoo.com

研究連絡先のバックアップ

  • 名前:Muhammed Alpaslan Uludag, Research Assistant, MD
  • メール:muho.78@live.com

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

25年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Patients over 25 years of age
  • American Soc,ety of Anesthesiology (ASA) status I-III
  • Scheduled to undergo laparoscopic abdominal surgery
  • With an expected pneumoperitoneum duration of ≥1 hour

Exclusion Criteria:

  • Patients with ocular disease
  • Patients who have undergone cranial or ocular surgery
  • Patients with a history of laparotomy
  • Individuals with bullous lung disease
  • Patients with uncontrolled chronic obstructive lung disease
  • Patients with hemodynamic instability or decompensated heart failure
  • Patients who require conversion to an open surgical procedure for any reason

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:診断
  • 割り当て:非ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
他の:Group O

Obese patients with BMI ≥ 30 kg/m²

Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting)

ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value.

他の:Group N

Non-obese patients

Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting)

ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Optic nerve sheath diameter (ONSD)
時間枠:Perioperative/Periprocedural (t0-after anesthesia induction and entubation)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t0-after anesthesia induction and entubation)
Optic nerve sheath diameter (ONSD)
時間枠:Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)
Optic nerve sheath diameter (ONSD)
時間枠:Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)
Optic nerve sheath diameter (ONSD)
時間枠:Perioperative/Periprocedural (t3 - after desufflation)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t3 - after desufflation)
Optic nerve sheath diameter (ONSD)
時間枠:Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)
Optic nerve sheath diameter (ONSD)
時間枠:Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)

二次結果の測定

結果測定
メジャーの説明
時間枠
MAP
時間枠:Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)

Noninvasive mean arterial pressure (mmHg)

Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)
HR
時間枠:Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)

Heart rate (beat/min)

Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)
etCO2
時間枠:Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)

End-tidal carbon dioxide levels (mmHg)

Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)

その他の成果指標

結果測定
メジャーの説明
時間枠
Airway pressures during mechanical ventilation
時間枠:Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)

Ppeak, Pplato, Driving pressure (∆P), PEEP levels (cmH20) will be recorded from the sama ventilation monitor screen

Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)
Postoperative complications
時間枠:PONV will be questioned at the 24th hours

Postoperative nause and vomiting (PONV)

PONV will be questioned at the 24th hours
Postoperative complications
時間枠:Headache will be questioned at the 24th hours

Headache

Headache will be questioned at the 24th hours
Postoperative complications
時間枠:Visual disturbance will be questioned at the 24th hours

Visual disturbance

Visual disturbance will be questioned at the 24th hours

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年12月1日

一次修了 (推定)

2027年11月1日

研究の完了 (推定)

2027年11月1日

試験登録日

最初に提出

2026年11月3日

QC基準を満たした最初の提出物

2026年11月9日

最初の投稿 (実際)

2026年11月16日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月16日

QC基準を満たした最後の更新が送信されました

2026年11月9日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • E-25403353-050.04-260108454

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。